Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Bludigo Generic Name & Formulations
Legal Class
Rx
General Description
Indigotindisulfonate sodium 8mg/mL; dark blue soln for IV inj.
Pharmacological Class
Diagnostic aid.
How Supplied
Single-dose ampules (5mL)—5
Manufacturer
Generic Availability
NO
Bludigo Indications
Indications
As a visualization aid in the cystoscopic assessment of the integrity of the ureters following urological and gynecological open, robotic, or endoscopic surgical procedures.
Bludigo Dosage and Administration
Adult
Give 5mL by IV inj over 1min. Within 4–9mins after IV inj, blue color is detectable at the ureteral orifices.
Children
Not established.
Bludigo Contraindications
Not Applicable
Bludigo Boxed Warnings
Not Applicable
Bludigo Warnings/Precautions
Warnings/Precautions
Risk of severe or life-threatening cardiovascular reactions within 60mins after inj (eg, cardiac arrest, arrhythmia, asystole, 2nd degree AV block, hypotension, elevated BP, bradycardia, tachycardia); interrupt administration if reactions occur. Hypertension. Heart rate or conduction disorders. Closely monitor BP and cardiac rhythm during and following inj. Monitor for anaphylactic reactions. Have emergency equipment and trained personnel readily available. May transiently interfere with pulse oximetric methods. Potential for artifactual reduction in SpO2 in anesthetized patients. Renal impairment (eGFR <30mL/min): not recommended. Pregnancy. Nursing mothers.
Bludigo Pharmacokinetics
See Literature
Bludigo Interactions
Interactions
Increased risk for elevated blood pressure, hypotension, bradycardia with concomitant drugs that can cause bradycardia.
Bludigo Adverse Reactions
Adverse Reactions
Constipation, nausea, vomiting, abdominal pain, pyrexia, increased ALT, dysuria; hypersensitivity reactions.
Bludigo Clinical Trials
See Literature
Bludigo Note
Not Applicable
Bludigo Patient Counseling
See Literature
